Search arXivSearch

arXiv subjects

David Page

Publications and source records attributed to David Page.

At least 19 recordsLinked to original sources

Probably Approximately Correct Causal Discovery

The discovery of causal relationships is a foundational problem in artificial intelligence, statistics, epidemiology, economics, and beyond. While elegant theories exist for accurate causal discovery given infinite data, real-world applications are inherently resource-constrained. Effective methods for inferring causal relationships from observational data must perform well under finite data and time constraints, where "performing well" implies achieving high, though not perfect accuracy. In his seminal paper A Theory of the Learnable, Valiant highlighted the importance of resource constraints in supervised machine learning, introducing the concept of Probably Approximately Correct (PAC) learning as an alternative to exact learning. Inspired by Valiant's work, we propose the Probably Approximately Correct Causal (PACC) Discovery framework, which extends PAC learning principles to the causal field. This framework emphasizes both computational and sample efficiency for established causal methods such as propensity score techniques and instrumental variable approaches. Furthermore, we show that it can also provide theoretical guarantees for other widely used methods, such as the Self-Controlled Case Series (SCCS) method, which had previously lacked such guarantees.

stat.ML

Training Video Foundation Models with NVIDIA NeMo

Video Foundation Models (VFMs) have recently been used to simulate the real world to train physical AI systems and develop creative visual experiences. However, there are significant challenges in training large-scale, high quality VFMs that can generate high-quality videos. We present a scalable, open-source VFM training pipeline with NVIDIA NeMo, providing accelerated video dataset curation, multimodal data loading, and parallelized video diffusion model training and inference. We also provide a comprehensive performance analysis highlighting best practices for efficient VFM training and inference.

cs.CV

Cosmos World Foundation Model Platform for Physical AI

Physical AI needs to be trained digitally first. It needs a digital twin of itself, the policy model, and a digital twin of the world, the world model. In this paper, we present the Cosmos World Foundation Model Platform to help developers build customized world models for their Physical AI setups. We position a world foundation model as a general-purpose world model that can be fine-tuned into customized world models for downstream applications. Our platform covers a video curation pipeline, pre-trained world foundation models, examples of post-training of pre-trained world foundation models, and video tokenizers. To help Physical AI builders solve the most critical problems of our society, we make Cosmos open-source and our models open-weight with permissive licenses available via https://github.com/nvidia-cosmos/cosmos-predict1.

cs.CV

MALADE: Orchestration of LLM-powered Agents with Retrieval Augmented Generation for Pharmacovigilance

In the era of Large Language Models (LLMs), given their remarkable text understanding and generation abilities, there is an unprecedented opportunity to develop new, LLM-based methods for trustworthy medical knowledge synthesis, extraction and summarization. This paper focuses on the problem of Pharmacovigilance (PhV), where the significance and challenges lie in identifying Adverse Drug Events (ADEs) from diverse text sources, such as medical literature, clinical notes, and drug labels. Unfortunately, this task is hindered by factors including variations in the terminologies of drugs and outcomes, and ADE descriptions often being buried in large amounts of narrative text. We present MALADE, the first effective collaborative multi-agent system powered by LLM with Retrieval Augmented Generation for ADE extraction from drug label data. This technique involves augmenting a query to an LLM with relevant information extracted from text resources, and instructing the LLM to compose a response consistent with the augmented data. MALADE is a general LLM-agnostic architecture, and its unique capabilities are: (1) leveraging a variety of external sources, such as medical literature, drug labels, and FDA tools (e.g., OpenFDA drug information API), (2) extracting drug-outcome association in a structured format along with the strength of the association, and (3) providing explanations for established associations. Instantiated with GPT-4 Turbo or GPT-4o, and FDA drug label data, MALADE demonstrates its efficacy with an Area Under ROC Curve of 0.90 against the OMOP Ground Truth table of ADEs. Our implementation leverages the Langroid multi-agent LLM framework and can be found at https://github.com/jihyechoi77/malade.

cs.CL

Neural Markov Prolog

The recent rapid advance of AI has been driven largely by innovations in neural network architectures. A concomitant concern is how to understand these resulting systems. In this paper, we propose a tool to assist in both the design of further innovative architectures and the simple yet precise communication of their structure. We propose the language Neural Markov Prolog (NMP), based on both Markov logic and Prolog, as a means to both bridge first order logic and neural network design and to allow for the easy generation and presentation of architectures for images, text, relational databases, or other target data types or their mixtures.

cs.AI

Differentially Private Multi-Site Treatment Effect Estimation

Patient privacy is a major barrier to healthcare AI. For confidentiality reasons, most patient data remains in silo in separate hospitals, preventing the design of data-driven healthcare AI systems that need large volumes of patient data to make effective decisions. A solution to this is collective learning across multiple sites through federated learning with differential privacy. However, literature in this space typically focuses on differentially private statistical estimation and machine learning, which is different from the causal inference-related problems that arise in healthcare. In this work, we take a fresh look at federated learning with a focus on causal inference; specifically, we look at estimating the average treatment effect (ATE), an important task in causal inference for healthcare applications, and provide a federated analytics approach to enable ATE estimation across multiple sites along with differential privacy (DP) guarantees at each site. The main challenge comes from site heterogeneity -- different sites have different sample sizes and privacy budgets. We address this through a class of per-site estimation algorithms that reports the ATE estimate and its variance as a quality measure, and an aggregation algorithm on the server side that minimizes the overall variance of the final ATE estimate. Our experiments on real and synthetic data show that our method reliably aggregates private statistics across sites and provides better privacy-utility tradeoff under site heterogeneity than baselines.

cs.LG

On Neural Networks as Infinite Tree-Structured Probabilistic Graphical Models

Deep neural networks (DNNs) lack the precise semantics and definitive probabilistic interpretation of probabilistic graphical models (PGMs). In this paper, we propose an innovative solution by constructing infinite tree-structured PGMs that correspond exactly to neural networks. Our research reveals that DNNs, during forward propagation, indeed perform approximations of PGM inference that are precise in this alternative PGM structure. Not only does our research complement existing studies that describe neural networks as kernel machines or infinite-sized Gaussian processes, it also elucidates a more direct approximation that DNNs make to exact inference in PGMs. Potential benefits include improved pedagogy and interpretation of DNNs, and algorithms that can merge the strengths of PGMs and DNNs.

stat.ML

Variable Importance Matching for Causal Inference

Our goal is to produce methods for observational causal inference that are auditable, easy to troubleshoot, accurate for treatment effect estimation, and scalable to high-dimensional data. We describe a general framework called Model-to-Match that achieves these goals by (i) learning a distance metric via outcome modeling, (ii) creating matched groups using the distance metric, and (iii) using the matched groups to estimate treatment effects. Model-to-Match uses variable importance measurements to construct a distance metric, making it a flexible framework that can be adapted to various applications. Concentrating on the scalability of the problem in the number of potential confounders, we operationalize the Model-to-Match framework with LASSO. We derive performance guarantees for settings where LASSO outcome modeling consistently identifies all confounders (importantly without requiring the linear model to be correctly specified). We also provide experimental results demonstrating the method's auditability, accuracy, and scalability as well as extensions to more general nonparametric outcome modeling.

stat.ME

Predicting Drug-Drug Interactions from Heterogeneous Data: An Embedding Approach

Predicting and discovering drug-drug interactions (DDIs) using machine learning has been studied extensively. However, most of the approaches have focused on text data or textual representation of the drug structures. We present the first work that uses multiple data sources such as drug structure images, drug structure string representation and relational representation of drug relationships as the input. To this effect, we exploit the recent advances in deep networks to integrate these varied sources of inputs in predicting DDIs. Our empirical evaluation against several state-of-the-art methods using standalone different data types for drugs clearly demonstrate the efficacy of combining heterogeneous data in predicting DDIs.

cs.LG

High-Throughput Approach to Modeling Healthcare Costs Using Electronic Healthcare Records

Accurate estimation of healthcare costs is crucial for healthcare systems to plan and effectively negotiate with insurance companies regarding the coverage of patient-care costs. Greater accuracy in estimating healthcare costs would provide mutual benefit for both health systems and the insurers that support these systems by better aligning payment models with patient-care costs. This study presents the results of a generalizable machine learning approach to predicting medical events built from 40 years of data from >860,000 patients pertaining to >6,700 prescription medications, courtesy of Marshfield Clinic in Wisconsin. It was found that models built using this approach performed well when compared to similar studies predicting physician prescriptions of individual medications. In addition to providing a comprehensive predictive model for all drugs in a large healthcare system, the approach taken in this research benefits from potential applicability to a wide variety of other medical events.

cs.LG

Stochastic Learning for Sparse Discrete Markov Random Fields with Controlled Gradient Approximation Error

We study the $L_1$-regularized maximum likelihood estimator/estimation (MLE) problem for discrete Markov random fields (MRFs), where efficient and scalable learning requires both sparse regularization and approximate inference. To address these challenges, we consider a stochastic learning framework called stochastic proximal gradient (SPG; Honorio 2012a, Atchade et al. 2014,Miasojedow and Rejchel 2016). SPG is an inexact proximal gradient algorithm [Schmidtet al., 2011], whose inexactness stems from the stochastic oracle (Gibbs sampling) for gradient approximation - exact gradient evaluation is infeasible in general due to the NP-hard inference problem for discrete MRFs [Koller and Friedman, 2009]. Theoretically, we provide novel verifiable bounds to inspect and control the quality of gradient approximation. Empirically, we propose the tighten asymptotically (TAY) learning strategy based on the verifiable bounds to boost the performance of SPG.

cs.LG

Temporal Poisson Square Root Graphical Models

We propose temporal Poisson square root graphical models (TPSQRs), a generalization of Poisson square root graphical models (PSQRs) specifically designed for modeling longitudinal event data. By estimating the temporal relationships for all possible pairs of event types, TPSQRs can offer a holistic perspective about whether the occurrences of any given event type could excite or inhibit any other type. A TPSQR is learned by estimating a collection of interrelated PSQRs that share the same template parameterization. These PSQRs are estimated jointly in a pseudo-likelihood fashion, where Poisson pseudo-likelihood is used to approximate the original more computationally-intensive pseudo-likelihood problem stemming from PSQRs. Theoretically, we demonstrate that under mild assumptions, the Poisson pseudo-likelihood approximation is sparsistent for recovering the underlying PSQR. Empirically, we learn TPSQRs from Marshfield Clinic electronic health records (EHRs) with millions of drug prescription and condition diagnosis events, for adverse drug reaction (ADR) detection. Experimental results demonstrate that the learned TPSQRs can recover ADR signals from the EHR effectively and efficiently.

cs.LG

CAUSE: Learning Granger Causality from Event Sequences using Attribution Methods

We study the problem of learning Granger causality between event types from asynchronous, interdependent, multi-type event sequences. Existing work suffers from either limited model flexibility or poor model explainability and thus fails to uncover Granger causality across a wide variety of event sequences with diverse event interdependency. To address these weaknesses, we propose CAUSE (Causality from AttribUtions on Sequence of Events), a novel framework for the studied task. The key idea of CAUSE is to first implicitly capture the underlying event interdependency by fitting a neural point process, and then extract from the process a Granger causality statistic using an axiomatic attribution method. Across multiple datasets riddled with diverse event interdependency, we demonstrate that CAUSE achieves superior performance on correctly inferring the inter-type Granger causality over a range of state-of-the-art methods.

cs.LG

AutoBlock: A Hands-off Blocking Framework for Entity Matching

Entity matching seeks to identify data records over one or multiple data sources that refer to the same real-world entity. Virtually every entity matching task on large datasets requires blocking, a step that reduces the number of record pairs to be matched. However, most of the traditional blocking methods are learning-free and key-based, and their successes are largely built on laborious human effort in cleaning data and designing blocking keys. In this paper, we propose AutoBlock, a novel hands-off blocking framework for entity matching, based on similarity-preserving representation learning and nearest neighbor search. Our contributions include: (a) Automation: AutoBlock frees users from laborious data cleaning and blocking key tuning. (b) Scalability: AutoBlock has a sub-quadratic total time complexity and can be easily deployed for millions of records. (c) Effectiveness: AutoBlock outperforms a wide range of competitive baselines on multiple large-scale, real-world datasets, especially when datasets are dirty and/or unstructured.

cs.DB

Beyond Textual Data: Predicting Drug-Drug Interactions from Molecular Structure Images using Siamese Neural Networks

Predicting and discovering drug-drug interactions (DDIs) is an important problem and has been studied extensively both from medical and machine learning point of view. Almost all of the machine learning approaches have focused on text data or textual representation of the structural data of drugs. We present the first work that uses drug structure images as the input and utilizes a Siamese convolutional network architecture to predict DDIs.

cs.LG

High-Throughput Machine Learning from Electronic Health Records

The widespread digitization of patient data via electronic health records (EHRs) has created an unprecedented opportunity to use machine learning algorithms to better predict disease risk at the patient level. Although predictive models have previously been constructed for a few important diseases, such as breast cancer and myocardial infarction, we currently know very little about how accurately the risk for most diseases or events can be predicted, and how far in advance. Machine learning algorithms use training data rather than preprogrammed rules to make predictions and are well suited for the complex task of disease prediction. Although there are thousands of conditions and illnesses patients can encounter, no prior research simultaneously predicts risks for thousands of diagnosis codes and thereby establishes a comprehensive patient risk profile. Here we show that such pandiagnostic prediction is possible with a high level of performance across diagnosis codes. For the tasks of predicting diagnosis risks both 1 and 6 months in advance, we achieve average areas under the receiver operating characteristic curve (AUCs) of 0.803 and 0.758, respectively, across thousands of prediction tasks. Finally, our research contributes a new clinical prediction dataset in which researchers can explore how well a diagnosis can be predicted and what health factors are most useful for prediction. For the first time, we can get a much more complete picture of how well risks for thousands of different diagnosis codes can be predicted.

q-bio.QM

A Simple Text Mining Approach for Ranking Pairwise Associations in Biomedical Applications

We present a simple text mining method that is easy to implement, requires minimal data collection and preparation, and is easy to use for proposing ranked associations between a list of target terms and a key phrase. We call this method KinderMiner, and apply it to two biomedical applications. The first application is to identify relevant transcription factors for cell reprogramming, and the second is to identify potential drugs for investigation in drug repositioning. We compare the results from our algorithm to existing data and state-of-the-art algorithms, demonstrating compelling results for both application areas. While we apply the algorithm here for biomedical applications, we argue that the method is generalizable to any available corpus of sufficient size.

cs.IR

Machine Learning to Predict Developmental Neurotoxicity with High-throughput Data from 2D Bio-engineered Tissues

There is a growing need for fast and accurate methods for testing developmental neurotoxicity across several chemical exposure sources. Current approaches, such as in vivo animal studies, and assays of animal and human primary cell cultures, suffer from challenges related to time, cost, and applicability to human physiology. We previously demonstrated success employing machine learning to predict developmental neurotoxicity using gene expression data collected from human 3D tissue models exposed to various compounds. The 3D model is biologically similar to developing neural structures, but its complexity necessitates extensive expertise and effort to employ. By instead focusing solely on constructing an assay of developmental neurotoxicity, we propose that a simpler 2D tissue model may prove sufficient. We thus compare the accuracy of predictive models trained on data from a 2D tissue model with those trained on data from a 3D tissue model, and find the 2D model to be substantially more accurate. Furthermore, we find the 2D model to be more robust under stringent gene set selection, whereas the 3D model suffers substantial accuracy degradation. While both approaches have advantages and disadvantages, we propose that our described 2D approach could be a valuable tool for decision makers when prioritizing neurotoxicity screening.

q-bio.QM